Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Oral Fluid Testing Approach
Sponsor: Boston Children's Hospital
Summary
The purpose of this study is to identify and evaluate oral fluid testing as a biologic measure of cannabis use days that can be assessed remotely. The researchers will conduct this fully virtual study among a community sample of 200 individuals aged 18-30 years who have used cannabis at least 1 time per week on average in the past 30 days. Participants will complete oral fluid (saliva) tests, urine tests, and Timeline Follow-back interviews (self-report) that indicate their recent cannabis use (delta-9-THC). Participants will present for 3 virtual study visits across \~3-4 weeks and be asked to complete activities in between: Study Visit 1 (Day 0; informed consent, baseline survey, TLFB interview), Study Visit 2 (\~Day 7; TLFB interview, urine testing), 6 days of at-home videorecorded oral fluid testing, Study Visit 3 (\~Day 21; TLFB interview, urine test, oral fluid test, survey, interview).
Official title: Oral Fluid Testing to Assess Cannabis Non-Use in Remote Clinical Trials
Key Details
Gender
All
Age Range
18 Years - 30 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-10-27
Completion Date
2027-05
Last Updated
2026-03-11
Healthy Volunteers
No
Interventions
Biologic testing for THC
Participants will be asked to complete at-home urine test(s) and a series of oral fluid tests.
Locations (1)
Boston Children's Hospital
Boston, Massachusetts, United States